1375.T
Yukiguni Maitake Co., Ltd. [1375.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1375.T Stock Summary
Top 10 Correlated ETFs
1375.T
Top 10 Correlated Stocks
1375.T
In the News
1375.T Financial details
Company Rating
Strong Buy
Market Cap
38.4B
Income
1.34B
Revenue
43.07B
Book val./share
276.25
Cash/share
50.71
Dividend
20
Dividend %
2.08%
Employees
1.09K
Optionable
No
Shortable
Yes
Earnings
02 Aug 2023
P/E
28.72
Forward P/E
-
PEG
-4
P/S
0.89
P/B
3.49
P/C
18.97
P/FCF
70.84
Quick Ratio
0.21
Current Ratio
1.08
Debt / Equity
1.75
LT Debt / Equity
1.47
-
-
EPS (TTM)
33.56
EPS next Y
-
EPS next Q
-
EPS this Y
-37.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.51%
Revenue last 5Y
10.31%
Revenue Q/Q
60.47%
EPS Q/Q
119.89%
-
-
-
-
SMA20
-5.92%
SMA50
-5.31%
SMA100
-3.68%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
13%
ROC
0.09%
Gross Margin
25%
Oper. Margin
6%
Profit Margin
3%
Payout
89%
Shs Outstand
39.87M
Shs Float
19.39M
-
-
-
-
Target Price
-
52W Range
845.0-1092.0
52W High
-11.9%
52W Low
+13.85%
RSI
39.3
Rel Volume
1.34
Avg Volume
71.57K
Volume
95.9K
Perf Week
1.26%
Perf Month
-4.66%
Perf Quarter
-3.51%
Perf Half Y
-2.63%
-
-
-
-
Beta
-0.116788
-
-
Volatility
5.95%, 26.88%
Prev Close
-0.1%
Price
962
Change
-0.21%
1375.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
| Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 1.19K | 1.27K | 1.29K | 1.18K | |
| Net income per share | 0 | 110.14 | 109.06 | 119.03 | 74.9 | |
| Operating cash flow per share | 0 | 200.6 | 122.74 | 205.84 | 140.48 | |
| Free cash flow per share | 0 | 139.97 | 63.04 | 112.23 | 76.06 | |
| Cash per share | 0 | 166.05 | 111.94 | 94.77 | 93.3 | |
| Book value per share | 0 | 57.92 | 122.94 | 231.66 | 262.4 | |
| Tangible book value per share | 0 | 57.99 | 122.96 | 231.61 | 262.37 | |
| Share holders equity per share | 0 | 57.92 | 122.94 | 231.66 | 262.4 | |
| Interest debt per share | 0 | 700.78 | 620.78 | 520.55 | 487.73 | |
| Market cap | 0 | 83.29B | 83.29B | 78.64B | 45.53B | |
| Enterprise value | 26.55B | 103.79B | 102.88B | 94.91B | 60.86B | |
| P/E ratio | 0 | 18.98 | 19.16 | 16.58 | 15.23 | |
| Price to sales ratio | 0 | 1.75 | 1.64 | 1.53 | 0.97 | |
| POCF ratio | 0 | 10.42 | 17.03 | 9.59 | 8.12 | |
| PFCF ratio | 0 | 14.93 | 33.16 | 17.58 | 15 | |
| P/B Ratio | 0 | 36.09 | 17 | 8.52 | 4.35 | |
| PTB ratio | 0 | 36.09 | 17 | 8.52 | 4.35 | |
| EV to sales | 0 | 2.18 | 2.03 | 1.85 | 1.29 | |
| Enterprise value over EBITDA | 0 | 11.81 | 11.31 | 9.68 | 8.74 | |
| EV to operating cash flow | 0 | 12.98 | 21.04 | 11.57 | 10.86 | |
| EV to free cash flow | 0 | 18.61 | 40.96 | 21.22 | 20.05 | |
| Earnings yield | 0 | 0.05 | 0.05 | 0.06 | 0.07 | |
| Free cash flow yield | 0 | 0.07 | 0.03 | 0.06 | 0.07 | |
| Debt to equity | -14.49 | 11.75 | 4.91 | 2.17 | 1.82 | |
| Debt to assets | 0.89 | 0.71 | 0.68 | 0.56 | 0.53 | |
| Net debt to EBITDA | 0 | 2.33 | 2.15 | 1.66 | 2.2 | |
| Current ratio | 1.55 | 1.51 | 1.52 | 1.34 | 1.22 | |
| Interest coverage | 0 | 8.09 | 9.85 | 11.19 | 11.99 | |
| Income quality | 0 | 1.26 | 0.74 | 1.15 | 1.23 | |
| Dividend Yield | 0 | 0 | 0.02 | 0.01 | 0.04 | |
| Payout ratio | 0 | 0 | 0.39 | 0.12 | 0.56 | |
| Sales general and administrative to revenue | 0 | 0.16 | 0.16 | 0.16 | 0.17 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.15 | 0.14 | 0.15 | 0.15 | 0.15 | |
| Capex to operating cash flow | 0 | -0.3 | -0.49 | -0.45 | -0.46 | |
| Capex to revenue | 0 | -0.05 | -0.05 | -0.07 | -0.05 | |
| Capex to depreciation | 0 | -1.45 | -1.34 | -1.89 | -1.3 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 378.85 | 549.24 | 787.66 | 665 | |
| ROIC | 0 | 0.22 | 0.18 | 0.2 | 0.13 | |
| Return on tangible assets | 0 | 0.13 | 0.15 | 0.16 | 0.1 | |
| Graham Net | 0 | -684.47 | -594.29 | -514.08 | -499.49 | |
| Working capital | 3.58B | 4.86B | 3.77B | 2.59B | 1.73B | |
| Tangible asset value | -7.23B | -2.96B | -420M | 3.93B | 5.18B | |
| Net current asset value | -25.83B | -21.41B | -19.25B | -16.21B | -15.89B | |
| Invested capital | -14.49 | 11.75 | 4.91 | 2.17 | 1.82 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 3.73B | 3.31B | 2.18B | 2.29B | |
| Average inventory | 0 | 3.58B | 4.13B | 4.3B | 4.12B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 46.33 | 24.72 | 20.5 | 28.16 | |
| Days of inventory on hand | 0 | 43.32 | 44.58 | 44.68 | 42.66 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 7.88 | 14.77 | 17.81 | 12.96 | |
| Inventory turnover | 0 | 8.42 | 8.19 | 8.17 | 8.56 | |
| ROE | 0 | 1.9 | 0.89 | 0.51 | 0.29 | |
| Capex per share | 0 | -60.63 | -59.7 | -93.61 | -64.43 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
| Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 399.72 | 266.18 | 205.67 | 233.53 | 374.74 | |
| Net income per share | 46.76 | -9.92 | -3.96 | 14.82 | 32.61 | |
| Operating cash flow per share | 99.5 | 50.62 | -26.69 | -8 | 80.94 | |
| Free cash flow per share | 85.44 | 25.33 | -40.81 | -36.59 | 65.64 | |
| Cash per share | 69.98 | 93.29 | 31.2 | 17.53 | 50.71 | |
| Book value per share | 274.12 | 262.39 | 242.64 | 257.54 | 276.25 | |
| Tangible book value per share | 274.09 | 262.37 | 242.64 | 257.54 | 276.25 | |
| Share holders equity per share | 274.12 | 262.39 | 242.64 | 257.54 | 276.25 | |
| Interest debt per share | 478.93 | 479.86 | 477.13 | 503.19 | 487.03 | |
| Market cap | 47.73B | 45.53B | 35.88B | 39.79B | 40.19B | |
| Enterprise value | 63.95B | 60.86B | 53.56B | 59.05B | 57.48B | |
| P/E ratio | 6.4 | -28.75 | -56.78 | 16.83 | 7.73 | |
| Price to sales ratio | 2.99 | 4.29 | 4.38 | 4.27 | 2.69 | |
| POCF ratio | 12.02 | 22.54 | -33.72 | -124.73 | 12.45 | |
| PFCF ratio | 14 | 45.04 | -22.05 | -27.27 | 15.36 | |
| P/B Ratio | 4.36 | 4.35 | 3.71 | 3.88 | 3.65 | |
| PTB ratio | 4.36 | 4.35 | 3.71 | 3.88 | 3.65 | |
| EV to sales | 4.01 | 5.73 | 6.53 | 6.34 | 3.85 | |
| Enterprise value over EBITDA | 18.79 | 1.79K | 156.61 | 39.21 | 21.94 | |
| EV to operating cash flow | 16.1 | 30.13 | -50.34 | -185.12 | 17.81 | |
| EV to free cash flow | 18.75 | 60.2 | -32.92 | -40.48 | 21.97 | |
| Earnings yield | 0.04 | -0.01 | 0 | 0.01 | 0.03 | |
| Free cash flow yield | 0.07 | 0.02 | -0.05 | -0.04 | 0.07 | |
| Debt to equity | 1.74 | 1.82 | 1.96 | 1.94 | 1.75 | |
| Debt to assets | 0.5 | 0.53 | 0.57 | 0.57 | 0.52 | |
| Net debt to EBITDA | 4.77 | 450.74 | 51.69 | 12.79 | 6.6 | |
| Current ratio | 1.27 | 1.22 | 1.02 | 1.09 | 1.08 | |
| Interest coverage | 28.16 | -4.69 | -1.58 | 9.78 | 20.77 | |
| Income quality | 1.42 | -3.51 | 4.12 | -0.36 | 1.63 | |
| Dividend Yield | 0.01 | 0 | 0.02 | 0 | 0.01 | |
| Payout ratio | 0.3 | -0.01 | -3.89 | 0.04 | 0.43 | |
| Sales general and administrative to revenue | 0.14 | 0.2 | 0.22 | 0.2 | 0.16 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.14 | 0.15 | 0.16 | 0.15 | 0.14 | |
| Capex to operating cash flow | -0.14 | -0.5 | 0.53 | 3.57 | -0.19 | |
| Capex to revenue | -0.04 | -0.09 | -0.07 | -0.12 | -0.04 | |
| Capex to depreciation | -1.12 | -1.99 | -1.13 | -2.16 | -1.12 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 537 | 242.05 | 147.09 | 293.08 | 450.18 | |
| ROIC | 0.07 | -0.01 | 0 | 0.02 | 0.05 | |
| Return on tangible assets | 0.06 | -0.01 | -0.01 | 0.02 | 0.04 | |
| Graham Net | -534.74 | -499.48 | -509.71 | -533.6 | -540.44 | |
| Working capital | 2.49B | 1.73B | 151M | 667M | 814M | |
| Tangible asset value | 5.64B | 5.18B | 4.39B | 4.98B | 5.73B | |
| Net current asset value | -15.09B | -15.89B | -16.76B | -16.29B | -15.42B | |
| Invested capital | 1.74 | 1.82 | 1.96 | 1.94 | 1.75 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 3.48B | 3.36B | 2.65B | 2.63B | 3.21B | |
| Average inventory | 5.52B | 4.67B | 3.89B | 4.52B | 5.13B | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 34.39 | 26.7 | 36.82 | 35.88 | 33.02 | |
| Days of inventory on hand | 45.12 | 40.44 | 52.56 | 72.83 | 43.34 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 2.62 | 3.37 | 2.44 | 2.51 | 2.73 | |
| Inventory turnover | 1.99 | 2.23 | 1.71 | 1.24 | 2.08 | |
| ROE | 0.17 | -0.04 | -0.02 | 0.06 | 0.12 | |
| Capex per share | -14.06 | -25.28 | -14.12 | -28.59 | -15.3 |
1375.T Frequently Asked Questions
What is Yukiguni Maitake Co., Ltd. stock symbol ?
Yukiguni Maitake Co., Ltd. is a JP stock and trading under the symbol 1375.T
What is Yukiguni Maitake Co., Ltd. stock quote today ?
Yukiguni Maitake Co., Ltd. stock price is $962 today.
Is Yukiguni Maitake Co., Ltd. stock public?
Yes, Yukiguni Maitake Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 71.57K
- Market Capitalization 38.4B
- Employee 1.09K
- CEO Mr. Masafumi Yuzawa
- Headquarters Minamiuonuma,JP
- IPO Date 2020-09-17
-
Website
https://www.maitake.co.jp 
Yukiguni Maitake Co., Ltd., together with its subsidiaries, manufactures and sells mushrooms and other processed food in Japan. The company's products include Maitake, Eringi, and Buna-Shimeji mushrooms; Maitake and Eringi rice mix; aojiru, a green juice health drink; and health foods. Yukiguni Maitake Co., Ltd. was founded in 1983 and is headquartered in Minamiuonuma, Japan. Yukiguni Maitake Co., Ltd. operates as a subsidiary of Shinmei Co., Ltd.
